Molecular Formula | C35H32FN5O4S2
|
Molar Mass | 669.79 |
Density | 1.45±0.1 g/cm3(Predicted) |
Solubility | DMSO: ≥ 31 mg/mL |
pKa | 1.11±0.36(Predicted) |
Storage Condition | -20℃ |
In vitro study | A- 1155463 disrupts the BCL-XL-BIM complex but not the BCL-2-BIM complex in the cell. A- 1155463 could kill BCL-XL-dependent Molt-4 cells (IC50=70 nM), but showed no significant cytotoxicity to RS4;11 cells (EC50>5 mM). A- 1155463 induced apoptosis markers in BCL-XL-dependent H146 cells, such as mitochondrial release of cytochrome c, caspase activation, and caspase-dependent sub-G0-G1-phase DNA content accumulation. |
In vivo study | After A single intraperitoneal injection of 5 mg/kg A- 1155463 into SCID-Beige tumor-free mice, the number of platelets decreased significantly at 6 hours after injection and returned to normal levels within 72 hours after injection. SCID-Beige mice inoculated with BCL-XL-dependent H146 tumor cells were intraperitoneally injected with 5 mg/kg A- 1155463 every day. After 14 days, the A- 1155463 significantly inhibited the growth of tumors, the effect is reduced. |